Traditional oral agents including metformin (if not already prescribed), sulfonylureas (which carry hypoglycaemia risk), or pioglitazone (which may cause fluid retention and increased heart failure risk) remain valid options, though each has its own side effect profile and contraindications
Well-designed randomized clinical studies are needed to systematically evaluate the evidence for the use of these hepatoprotective agents as treatment options for APAP-induced liver injury, to determine the timing of initiation of the therapy, and to further define the optimal treatment regimen
As natural catastrophes continue to grow in frequency and severity, enhancing a business continuity strategy helps ensure organizations are prepared for the unexpected
For instance, Shotsy includes a medication level estimator, which visualizes how much of the drug remains in your system based on its half-life
Clinical trials for current FDA-approved weight management medications show varying degrees of effectiveness: GLP-1 and Dual Agonists (Semaglutide, Tirzepatide): These medications have shown the most substantial weight loss